Gordon, Alan N <br/><br/>
Phase I study of alternating doublets of topotecan/carboplatin and paclitaxel/carboplatin in patients with newly diagnosed, advanced ovarian cancer.  [electronic resource] 

 -  Gynecologic oncology  Apr 2002 
 - 129-35 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>0090-8258 
<br/><br/><label>Standard No.: </label>10.1006/gyno.2001.6581  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>CA-125 Antigen--blood<br/>Carboplatin--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Middle Aged<br/>Neoplasm Staging<br/>Ovarian Neoplasms--blood<br/>Paclitaxel--administration & dosage<br/>Topotecan--administration & dosage